Tower Research Capital (TRC)’s ONYX PHARMACEUTICALS INC ONXX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2013
Q4
Sell
-969
Closed -$121K 5460
2013
Q3
$121K Buy
969
+967
+48,350% +$122K 0.01% 1126
2013
Q2
$0 Buy
+2
New +$184 ﹤0.01% 4067

Tower Research Capital (TRC)'s ONXX Position: Q4 2013 in Review

Tower Research Capital (TRC) sold out of ONYX PHARMACEUTICALS INC (ONXX) in Q4 2013, closing a stake of 969 shares — an estimated $121K sold.

Tower Research Capital (TRC) first reported a position in ONXX in Q2 2013 and held it in 2 quarters. The position peaked at $121K in Q3 2013. 0 funds tracked by Wall St. Rank hold ONXX as of Q4 2013.

  • Tower Research Capital (TRC) reported no remaining ONYX PHARMACEUTICALS INC position as of Q4 2013 after selling out during the quarter.
  • Tower Research Capital (TRC) sold 969 ONYX PHARMACEUTICALS INC shares in Q4 2013, an estimated $121K.
  • Tower Research Capital (TRC) first reported a position in ONYX PHARMACEUTICALS INC in Q2 2013 and held it in 2 quarters.
  • Tower Research Capital (TRC)'s ONYX PHARMACEUTICALS INC position peaked at $121K in Q3 2013.
  • 0 funds tracked by Wall St. Rank held ONYX PHARMACEUTICALS INC as of Q4 2013.

Based on Tower Research Capital (TRC)'s 13F filing for Q4 2013, filed 31 Jan 2014.